Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

PPARs in the brain.

Michael T Heneka1, Gary E Landreth

  • 1Department of Neurology, Molecular Neurology Unit, Mendelstrasse 7, University of Münster, Albert Schweitzer-Strasse 33, 48149 Münster, Germany. heneka@uni-muenster.de

Biochimica Et Biophysica Acta
|June 16, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Human IL-34 Deficiency Primes Microglia Toward Alzheimer's Disease-Associated States.

medRxiv : the preprint server for health sciences·2026
Same author

Landscape of copy number variants in Spanish people with dementia.

NPJ genomic medicine·2026
Same author

Regulatory mechanisms driven by functional 3'-UTR variants in alcohol use disorder and related traits.

Genome biology·2026
Same author

Neuroinflammation and neurodegeneration trigger a specific splice form of ribosomal protein S24.

Brain : a journal of neurology·2026
Same author

MOLT: multi-object and lineage tracking in 2D and 3D biomedical time-series imaging.

BMC bioinformatics·2026
Same author

Therapeutic Targeting of Microglial Hexokinase-2 Recalibrates Inflammasome Activation and Improves Functional Recovery After Traumatic Brain Injury.

bioRxiv : the preprint server for biology·2026

Peroxisome proliferator-activated receptors (PPARs) show promise in treating neurodegenerative diseases like Multiple Sclerosis and Alzheimer's by reducing inflammation and potentially offering neuroprotection.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pharmacology

Background:

  • Peroxisome proliferator-activated receptors (PPARs) are increasingly recognized for their role in central nervous system (CNS) disorders.
  • While primarily studied in peripheral tissues, PPARs, particularly PPARgamma, are now understood to be crucial in CNS pathogenesis.
  • Inflammation is a key component in several neurodegenerative diseases, making PPARs a potential therapeutic target.

Purpose of the Study:

  • To evaluate the therapeutic potential of PPAR activation in CNS disorders with an inflammatory component.
  • To investigate the role of PPARgamma in neurodegenerative diseases such as Multiple Sclerosis, Alzheimer's disease, Parkinson's disease, and Amyotrophic Lateral Sclerosis.
  • To explore the mechanisms underlying PPAR-mediated neuroprotection, including anti-inflammatory and anti-amyloidogenic effects.

Related Experiment Videos

Main Methods:

  • In vitro and in vivo studies using murine models of Multiple Sclerosis.
  • Analysis of human cells to verify findings from animal models.
  • Utilizing Alzheimer's disease-related transgenic cellular and animal models to test PPAR activation.
  • Investigating PPAR agonists in animal models of Parkinson's disease and Amyotrophic Lateral Sclerosis.

Main Results:

  • PPAR activation, especially PPARgamma, demonstrated protective effects in Multiple Sclerosis models.
  • Evidence suggests PPARgamma activation may mediate the neuroprotective effects of non-steroidal anti-inflammatory drugs (NSAIDs) in Alzheimer's disease.
  • PPAR agonists exhibited anti-amyloidogenic, anti-inflammatory, and insulin-sensitizing effects in Alzheimer's disease models.
  • Positive outcomes were observed in animal models of Parkinson's disease and Amyotrophic Lateral Sclerosis, indicating potential neuroprotection.

Conclusions:

  • PPAR activation holds significant therapeutic potential for neuroinflammatory and neurodegenerative diseases.
  • Further clinical studies are warranted to elucidate the precise mechanisms of PPAR action in the CNS.
  • PPARs may play critical roles in CNS development, maintenance, and function, beyond their anti-inflammatory effects.